| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | lncRNA binding | 6.23e-05 | 35 | 7 | 2 | GO:0106222 | |
| GeneOntologyMolecularFunction | steroid binding | 9.05e-04 | 133 | 7 | 2 | GO:0005496 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.58e-03 | 739 | 7 | 3 | GO:0003682 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 3.45e-03 | 262 | 7 | 2 | GO:0140097 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 6.98e-03 | 1244 | 7 | 3 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 7.42e-03 | 1271 | 7 | 3 | GO:0000987 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 8.52e-03 | 417 | 7 | 2 | GO:0061629 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1.09e-02 | 1459 | 7 | 3 | GO:0000977 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.62e-02 | 582 | 7 | 2 | GO:0140297 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 1.96e-02 | 645 | 7 | 2 | GO:0140640 | |
| GeneOntologyCellularComponent | euchromatin | 2.43e-04 | 72 | 7 | 2 | GO:0000791 | |
| GeneOntologyCellularComponent | P-body | 4.87e-04 | 102 | 7 | 2 | GO:0000932 | |
| GeneOntologyCellularComponent | perikaryon | 2.30e-03 | 223 | 7 | 2 | GO:0043204 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 3.32e-03 | 269 | 7 | 2 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 3.77e-03 | 287 | 7 | 2 | GO:0035770 | |
| Pathway | REACTOME_SUMOYLATION | 7.98e-05 | 189 | 7 | 3 | M27214 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 2.25e-03 | 149 | 7 | 2 | M27888 | |
| Pathway | REACTOME_SUMOYLATION | 2.88e-03 | 169 | 7 | 2 | MM14919 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 4.84e-03 | 220 | 7 | 2 | M27794 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 5.59e-03 | 237 | 7 | 2 | M27786 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 8.61e-03 | 296 | 7 | 2 | M27869 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 9.59e-03 | 313 | 7 | 2 | M27867 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 1.07e-02 | 1022 | 7 | 3 | MM15436 | |
| Pubmed | 2.08e-07 | 4 | 7 | 2 | 24464625 | ||
| Pubmed | Cytoplasmic compartmentalization of the fetal piRNA pathway in mice. | 2.29e-06 | 12 | 7 | 2 | 20011505 | |
| Pubmed | 6.59e-06 | 20 | 7 | 2 | 20059948 | ||
| Pubmed | 2.78e-05 | 326 | 7 | 3 | 17015433 | ||
| Pubmed | The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically. | 7.40e-05 | 66 | 7 | 2 | 32051553 | |
| Pubmed | 9.31e-05 | 74 | 7 | 2 | 24952347 | ||
| Interaction | MPHOSPH8 interactions | 3.29e-06 | 93 | 7 | 3 | int:MPHOSPH8 | |
| Interaction | PCF11 interactions | 5.60e-06 | 111 | 7 | 3 | int:PCF11 | |
| Interaction | NCOA6 interactions | 1.25e-05 | 145 | 7 | 3 | int:NCOA6 | |
| Interaction | GTF2E2 interactions | 2.59e-05 | 185 | 7 | 3 | int:GTF2E2 | |
| Interaction | MED17 interactions | 3.37e-05 | 202 | 7 | 3 | int:MED17 | |
| Interaction | CBX4 interactions | 3.52e-05 | 205 | 7 | 3 | int:CBX4 | |
| Interaction | POLR2H interactions | 4.53e-05 | 223 | 7 | 3 | int:POLR2H | |
| Interaction | CTR9 interactions | 5.16e-05 | 233 | 7 | 3 | int:CTR9 | |
| Interaction | CDC16 interactions | 6.07e-05 | 246 | 7 | 3 | int:CDC16 | |
| Interaction | H2BC4 interactions | 7.07e-05 | 259 | 7 | 3 | int:H2BC4 | |
| Interaction | ARID1A interactions | 8.54e-05 | 276 | 7 | 3 | int:ARID1A | |
| Interaction | RBBP5 interactions | 9.59e-05 | 287 | 7 | 3 | int:RBBP5 | |
| Interaction | TTN interactions | 1.08e-04 | 299 | 7 | 3 | int:TTN | |
| Interaction | IRF9 interactions | 1.11e-04 | 47 | 7 | 2 | int:IRF9 | |
| Interaction | NAT10 interactions | 1.12e-04 | 302 | 7 | 3 | int:NAT10 | |
| Interaction | NKX3-1 interactions | 1.36e-04 | 52 | 7 | 2 | int:NKX3-1 | |
| Interaction | POLR2C interactions | 1.56e-04 | 338 | 7 | 3 | int:POLR2C | |
| Interaction | CPSF7 interactions | 1.56e-04 | 338 | 7 | 3 | int:CPSF7 | |
| Interaction | CNOT6 interactions | 1.58e-04 | 56 | 7 | 2 | int:CNOT6 | |
| Interaction | TERF2 interactions | 1.58e-04 | 340 | 7 | 3 | int:TERF2 | |
| Interaction | FOXO1 interactions | 1.68e-04 | 347 | 7 | 3 | int:FOXO1 | |
| Interaction | PIAS1 interactions | 1.77e-04 | 353 | 7 | 3 | int:PIAS1 | |
| Interaction | MCM3 interactions | 1.80e-04 | 355 | 7 | 3 | int:MCM3 | |
| Interaction | INTS8 interactions | 1.94e-04 | 62 | 7 | 2 | int:INTS8 | |
| Interaction | H2AZ1 interactions | 2.05e-04 | 371 | 7 | 3 | int:H2AZ1 | |
| Interaction | CLP1 interactions | 2.26e-04 | 67 | 7 | 2 | int:CLP1 | |
| Interaction | FBXO32 interactions | 2.30e-04 | 386 | 7 | 3 | int:FBXO32 | |
| Interaction | TDG interactions | 2.40e-04 | 69 | 7 | 2 | int:TDG | |
| Interaction | TRIM24 interactions | 2.52e-04 | 398 | 7 | 3 | int:TRIM24 | |
| Interaction | TBK1 interactions | 2.60e-04 | 402 | 7 | 3 | int:TBK1 | |
| Interaction | FAM184A interactions | 2.61e-04 | 72 | 7 | 2 | int:FAM184A | |
| Interaction | CNOT8 interactions | 2.76e-04 | 74 | 7 | 2 | int:CNOT8 | |
| Interaction | TXNL4A interactions | 2.99e-04 | 77 | 7 | 2 | int:TXNL4A | |
| Interaction | ZBTB17 interactions | 2.99e-04 | 77 | 7 | 2 | int:ZBTB17 | |
| Interaction | HDAC9 interactions | 3.07e-04 | 78 | 7 | 2 | int:HDAC9 | |
| Interaction | P4HB interactions | 3.10e-04 | 427 | 7 | 3 | int:P4HB | |
| Interaction | POLD2 interactions | 3.31e-04 | 81 | 7 | 2 | int:POLD2 | |
| Interaction | ZBTB2 interactions | 3.62e-04 | 450 | 7 | 3 | int:ZBTB2 | |
| Interaction | INTS9 interactions | 3.64e-04 | 85 | 7 | 2 | int:INTS9 | |
| Interaction | MED13 interactions | 3.73e-04 | 86 | 7 | 2 | int:MED13 | |
| Interaction | GPBP1L1 interactions | 3.73e-04 | 86 | 7 | 2 | int:GPBP1L1 | |
| Interaction | DNMT3L interactions | 3.90e-04 | 88 | 7 | 2 | int:DNMT3L | |
| Interaction | CMBL interactions | 3.90e-04 | 88 | 7 | 2 | int:CMBL | |
| Interaction | ATP9A interactions | 4.08e-04 | 90 | 7 | 2 | int:ATP9A | |
| Interaction | LAMB3 interactions | 4.08e-04 | 90 | 7 | 2 | int:LAMB3 | |
| Interaction | MGMT interactions | 4.27e-04 | 92 | 7 | 2 | int:MGMT | |
| Interaction | DHRS2 interactions | 4.36e-04 | 93 | 7 | 2 | int:DHRS2 | |
| Interaction | CNOT6L interactions | 4.36e-04 | 93 | 7 | 2 | int:CNOT6L | |
| Interaction | BRCA1 interactions | 4.42e-04 | 1249 | 7 | 4 | int:BRCA1 | |
| Interaction | MYH6 interactions | 4.45e-04 | 94 | 7 | 2 | int:MYH6 | |
| Interaction | JUP interactions | 4.51e-04 | 485 | 7 | 3 | int:JUP | |
| Interaction | POLR1G interactions | 4.62e-04 | 489 | 7 | 3 | int:POLR1G | |
| Interaction | FAM76B interactions | 4.94e-04 | 99 | 7 | 2 | int:FAM76B | |
| Interaction | EDRF1 interactions | 4.94e-04 | 99 | 7 | 2 | int:EDRF1 | |
| Interaction | SPTY2D1 interactions | 4.94e-04 | 99 | 7 | 2 | int:SPTY2D1 | |
| Interaction | PHF14 interactions | 5.04e-04 | 100 | 7 | 2 | int:PHF14 | |
| Interaction | MYLK2 interactions | 5.14e-04 | 101 | 7 | 2 | int:MYLK2 | |
| Interaction | MED6 interactions | 5.14e-04 | 101 | 7 | 2 | int:MED6 | |
| Interaction | MED27 interactions | 5.24e-04 | 102 | 7 | 2 | int:MED27 | |
| Interaction | INTS2 interactions | 5.24e-04 | 102 | 7 | 2 | int:INTS2 | |
| Interaction | PSPC1 interactions | 5.38e-04 | 515 | 7 | 3 | int:PSPC1 | |
| Interaction | CSTF1 interactions | 5.45e-04 | 104 | 7 | 2 | int:CSTF1 | |
| Interaction | NFYA interactions | 5.55e-04 | 105 | 7 | 2 | int:NFYA | |
| Interaction | VEZF1 interactions | 5.55e-04 | 105 | 7 | 2 | int:VEZF1 | |
| Interaction | PQBP1 interactions | 5.55e-04 | 105 | 7 | 2 | int:PQBP1 | |
| Interaction | POLR2A interactions | 6.05e-04 | 536 | 7 | 3 | int:POLR2A | |
| Interaction | TASOR interactions | 6.09e-04 | 110 | 7 | 2 | int:TASOR | |
| Interaction | BUD13 interactions | 6.09e-04 | 110 | 7 | 2 | int:BUD13 | |
| Interaction | INTS6 interactions | 6.09e-04 | 110 | 7 | 2 | int:INTS6 | |
| Interaction | AGFG1 interactions | 6.09e-04 | 110 | 7 | 2 | int:AGFG1 | |
| Interaction | CNOT11 interactions | 6.31e-04 | 112 | 7 | 2 | int:CNOT11 | |
| Interaction | RECQL5 interactions | 6.54e-04 | 114 | 7 | 2 | int:RECQL5 | |
| Interaction | TERF2IP interactions | 6.59e-04 | 552 | 7 | 3 | int:TERF2IP | |
| Interaction | INTS12 interactions | 6.65e-04 | 115 | 7 | 2 | int:INTS12 | |
| Interaction | AFF4 interactions | 6.65e-04 | 115 | 7 | 2 | int:AFF4 | |
| Interaction | KIAA2013 interactions | 6.77e-04 | 116 | 7 | 2 | int:KIAA2013 | |
| Interaction | IWS1 interactions | 6.77e-04 | 116 | 7 | 2 | int:IWS1 | |
| Interaction | NR2C2 interactions | 6.90e-04 | 1403 | 7 | 4 | int:NR2C2 | |
| Interaction | SFPQ interactions | 6.98e-04 | 563 | 7 | 3 | int:SFPQ | |
| Interaction | PHF3 interactions | 7.00e-04 | 118 | 7 | 2 | int:PHF3 | |
| Interaction | AGO4 interactions | 7.00e-04 | 118 | 7 | 2 | int:AGO4 | |
| Interaction | RBM6 interactions | 7.12e-04 | 119 | 7 | 2 | int:RBM6 | |
| Interaction | PSMD5 interactions | 7.24e-04 | 120 | 7 | 2 | int:PSMD5 | |
| Interaction | H2BC8 interactions | 7.46e-04 | 576 | 7 | 3 | int:H2BC8 | |
| Interaction | SYNE1 interactions | 7.61e-04 | 123 | 7 | 2 | int:SYNE1 | |
| Interaction | FBXL6 interactions | 7.73e-04 | 583 | 7 | 3 | int:FBXL6 | |
| Interaction | POU5F1 interactions | 7.77e-04 | 584 | 7 | 3 | int:POU5F1 | |
| Interaction | RCL1 interactions | 7.98e-04 | 126 | 7 | 2 | int:RCL1 | |
| Interaction | TRIM28 interactions | 8.34e-04 | 1474 | 7 | 4 | int:TRIM28 | |
| Interaction | KMT2B interactions | 8.49e-04 | 130 | 7 | 2 | int:KMT2B | |
| Interaction | EIF3J interactions | 8.49e-04 | 130 | 7 | 2 | int:EIF3J | |
| Interaction | TARBP2 interactions | 8.62e-04 | 131 | 7 | 2 | int:TARBP2 | |
| Interaction | THOC5 interactions | 8.62e-04 | 131 | 7 | 2 | int:THOC5 | |
| Interaction | SCAF11 interactions | 8.75e-04 | 132 | 7 | 2 | int:SCAF11 | |
| Interaction | TAP1 interactions | 8.88e-04 | 133 | 7 | 2 | int:TAP1 | |
| Interaction | HRNR interactions | 8.88e-04 | 133 | 7 | 2 | int:HRNR | |
| Interaction | SCD interactions | 9.02e-04 | 134 | 7 | 2 | int:SCD | |
| Interaction | KMT2C interactions | 9.02e-04 | 134 | 7 | 2 | int:KMT2C | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | 4.84e-04 | 646 | 7 | 3 | M2419 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | 5.51e-04 | 675 | 7 | 3 | MM1073 | |
| Coexpression | GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP | 7.16e-04 | 155 | 7 | 2 | M6500 | |
| Coexpression | GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP | 8.10e-04 | 165 | 7 | 2 | M337 | |
| Coexpression | GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_DN | 8.70e-04 | 171 | 7 | 2 | M7115 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 1.11e-03 | 193 | 7 | 2 | M6813 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 1.12e-03 | 194 | 7 | 2 | M2081 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP | 1.14e-03 | 196 | 7 | 2 | M7718 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 1.14e-03 | 196 | 7 | 2 | MM667 | |
| Coexpression | GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN | 1.15e-03 | 197 | 7 | 2 | M8025 | |
| Coexpression | GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.17e-03 | 199 | 7 | 2 | M5359 | |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP | 1.17e-03 | 199 | 7 | 2 | M5604 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 1.17e-03 | 199 | 7 | 2 | M6987 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_6H_BMDC_UP | 1.19e-03 | 200 | 7 | 2 | M3943 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_1H_BMDC_UP | 1.19e-03 | 200 | 7 | 2 | M3934 | |
| Coexpression | GSE17721_CTRL_VS_CPG_8H_BMDC_DN | 1.19e-03 | 200 | 7 | 2 | M3768 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 1.19e-03 | 200 | 7 | 2 | M291 | |
| Coexpression | GSE3039_NKT_CELL_VS_B1_BCELL_DN | 1.19e-03 | 200 | 7 | 2 | M6433 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP | 1.19e-03 | 200 | 7 | 2 | M4033 | |
| Coexpression | GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN | 1.19e-03 | 200 | 7 | 2 | M3199 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP | 1.19e-03 | 200 | 7 | 2 | M6611 | |
| Coexpression | GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN | 1.19e-03 | 200 | 7 | 2 | M3365 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_UP | 1.19e-03 | 200 | 7 | 2 | M3834 | |
| Coexpression | GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP | 1.19e-03 | 200 | 7 | 2 | M6248 | |
| Coexpression | GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN | 1.19e-03 | 200 | 7 | 2 | M8494 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_DN | 1.29e-03 | 209 | 7 | 2 | MM1058 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.24e-05 | 210 | 7 | 3 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.25e-05 | 230 | 7 | 3 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.85e-05 | 256 | 7 | 3 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.06e-05 | 259 | 7 | 3 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | 6.08e-05 | 790 | 7 | 4 | gudmap_developingGonad_e16.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 6.36e-05 | 799 | 7 | 4 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | 6.42e-05 | 801 | 7 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 2.41e-04 | 413 | 7 | 3 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500 | 1.38e-03 | 175 | 7 | 2 | gudmap_developingGonad_e14.5_ epididymis_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 1.54e-03 | 778 | 7 | 3 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | 1.63e-03 | 795 | 7 | 3 | gudmap_developingGonad_e16.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 1.65e-03 | 797 | 7 | 3 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 1.70e-03 | 806 | 7 | 3 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.74e-03 | 197 | 7 | 2 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.27e-03 | 225 | 7 | 2 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.45e-03 | 234 | 7 | 2 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.77e-03 | 249 | 7 | 2 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.36e-03 | 275 | 7 | 2 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.41e-03 | 277 | 7 | 2 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.51e-03 | 281 | 7 | 2 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.58e-03 | 284 | 7 | 2 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.48e-04 | 185 | 7 | 2 | e8f7da9641b6cf1db1093b4f301ce828fd3a529c | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_reticulocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.48e-04 | 185 | 7 | 2 | 4a2c85e292d4cbce80e92992ded5d66a3aa446ee | |
| ToppCell | Immune-enucleated_erythrocyte|World / Lineage, Cell type, age group and donor | 3.52e-04 | 186 | 7 | 2 | f9d5ec5cc8fd6e63bf25abe390307ec8a4a2d5a3 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|World / Lineage, cell class and subclass | 3.64e-04 | 189 | 7 | 2 | 826457adac7477102f86aceb97a8b77929b3e6f9 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.64e-04 | 189 | 7 | 2 | 1900e574870fc647bfa11c732a72f3d38aab717c | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells|World / Lineage, cell class and subclass | 3.67e-04 | 190 | 7 | 2 | 6c7e016a9b425ee9418acd4fe96b9779fe7bd39a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.71e-04 | 191 | 7 | 2 | f158e393976b685b896a41871bda1ab65a8b58f5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.71e-04 | 191 | 7 | 2 | 6e1d00404d795ec7cf60f685e42e4ad9a16ac596 | |
| ToppCell | Influenza_Severe-RBC|Influenza_Severe / Disease group and Cell class | 3.75e-04 | 192 | 7 | 2 | f19b6da3fd98da1a76d2570137a8f73a3850ebcb | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.79e-04 | 193 | 7 | 2 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.79e-04 | 193 | 7 | 2 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | severe_influenza-RBC|severe_influenza / disease group, cell group and cell class (v2) | 3.79e-04 | 193 | 7 | 2 | ffb0b3c2cce13b6891157f0fede2600f3938670e | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 3.83e-04 | 194 | 7 | 2 | f0ababe8daa57f6827a3e2e72c884d9e8b2687a3 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid-late_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.83e-04 | 194 | 7 | 2 | 23b06707d21306b4483d64cb350b86aef352ce38 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 3.91e-04 | 196 | 7 | 2 | 092caba6726d1acd409a8be335100764d0724e64 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 196 | 7 | 2 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.91e-04 | 196 | 7 | 2 | 51c48944149a89b98011a50fe81ca6664d5f0d44 | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.91e-04 | 196 | 7 | 2 | 2aeb792e7685e33e3543a6974be790980a41ed8c | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-04 | 196 | 7 | 2 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-04 | 197 | 7 | 2 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.95e-04 | 197 | 7 | 2 | b71da7f2fd8d526fb6e5d57e60fc08acdd8dbefb | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.03e-04 | 199 | 7 | 2 | c555d88b66939e7dff2cb44d1f8feb53fbd8bd82 | |
| ToppCell | Influenza-Influenza_Severe-Others-RBC|Influenza_Severe / Disease, condition lineage and cell class | 4.03e-04 | 199 | 7 | 2 | da0fec0a492bc3827d9066d2590bcd466cd45564 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.03e-04 | 199 | 7 | 2 | 8d0eb13a391a2ac1b4f332290c2d00a7fb42bddc | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.03e-04 | 199 | 7 | 2 | e9c83555d2197b740797a9f33b64f8f7a7ba1ee2 | |
| ToppCell | 10x5'v1-week_14-16-Hematopoietic-erythroid-mid_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.03e-04 | 199 | 7 | 2 | e6853b2c0ef6549d5554754c5d5f65825b66025b | |
| Drug | poly(dA-dC).poly(dG-dT | 8.10e-07 | 5 | 7 | 2 | CID000123709 | |
| Drug | isochroman | 7.36e-06 | 14 | 7 | 2 | CID000096266 | |
| Drug | GW5638 | 1.70e-05 | 21 | 7 | 2 | CID005288494 | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A | 2.11e-05 | 195 | 7 | 3 | 3712_UP | |
| Drug | Sulfachloropyridazine [80-32-0]; Up 200; 14uM; PC3; HT_HG-U133A | 2.18e-05 | 197 | 7 | 3 | 3769_UP | |
| Drug | Chlorpropamide [94-20-2]; Up 200; 14.4uM; PC3; HT_HG-U133A | 2.21e-05 | 198 | 7 | 3 | 6291_UP | |
| Drug | Rifampicin [13292-46-1]; Up 200; 4.8uM; PC3; HT_HG-U133A | 2.24e-05 | 199 | 7 | 3 | 4008_UP | |
| Drug | Procaine hydrochloride [51-05-8]; Up 200; 14.6uM; PC3; HT_HG-U133A | 2.28e-05 | 200 | 7 | 3 | 6329_UP | |
| Drug | isoxanthohumol | 3.05e-05 | 28 | 7 | 2 | CID000513197 | |
| Drug | CDRI-85/287 | 3.28e-05 | 29 | 7 | 2 | CID000159508 | |
| Drug | AC1Q6PCP | 3.46e-05 | 230 | 7 | 3 | CID000005267 | |
| Drug | poly(dG-dC).poly(dG-dC | 4.80e-05 | 35 | 7 | 2 | CID000065376 | |
| Drug | vinyl carbamate | 5.97e-05 | 39 | 7 | 2 | ctd:C017963 | |
| Drug | Demetric acid | 6.28e-05 | 40 | 7 | 2 | CID000025440 | |
| Drug | Organometallic Compounds | 7.62e-05 | 44 | 7 | 2 | ctd:D009942 | |
| Drug | Implanon | 8.70e-05 | 47 | 7 | 2 | CID000040976 | |
| Drug | vinclozolin | 9.08e-05 | 48 | 7 | 2 | CID000039676 | |
| Drug | Starlicide | 9.46e-05 | 49 | 7 | 2 | CID000007255 | |
| Drug | 8-prenylnaringenin | 1.07e-04 | 52 | 7 | 2 | CID000480764 | |
| Drug | pregna-4,17-diene-3,16-dione | 1.19e-04 | 55 | 7 | 2 | ctd:C023617 | |
| Drug | raloxifene | 1.21e-04 | 351 | 7 | 3 | CID000005035 | |
| Drug | sodium molybdate | 1.28e-04 | 57 | 7 | 2 | CID000061424 | |
| Drug | 1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane | 1.37e-04 | 59 | 7 | 2 | ctd:C517232 | |
| Drug | sulforhodamine B | 2.11e-04 | 73 | 7 | 2 | CID000065191 | |
| Drug | S-Adenosylmethionine | 2.17e-04 | 74 | 7 | 2 | ctd:D012436 | |
| Drug | 3,3'-diindolylmethane | 2.66e-04 | 82 | 7 | 2 | CID000003071 | |
| Disease | Neoplasm Recurrence, Local | 3.56e-05 | 39 | 7 | 2 | C0027643 | |
| Disease | sexual dimorphism measurement | 6.28e-05 | 1106 | 7 | 4 | EFO_0021796 | |
| Disease | body surface area | 3.38e-04 | 643 | 7 | 3 | EFO_0022196 | |
| Disease | Malignant Neoplasms | 3.87e-04 | 128 | 7 | 2 | C0006826 | |
| Disease | Malignant neoplasm of liver | 4.75e-04 | 142 | 7 | 2 | C0345904 | |
| Disease | Liver neoplasms | 4.75e-04 | 142 | 7 | 2 | C0023903 | |
| Disease | Disease Exacerbation | 6.41e-04 | 165 | 7 | 2 | C0235874 | |
| Disease | diet measurement | 1.41e-03 | 1049 | 7 | 3 | EFO_0008111 | |
| Disease | Malignant neoplasm of breast | 1.51e-03 | 1074 | 7 | 3 | C0006142 | |
| Disease | Lung Neoplasms | 1.64e-03 | 265 | 7 | 2 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.65e-03 | 266 | 7 | 2 | C0242379 | |
| Disease | waist-hip ratio | 2.21e-03 | 1226 | 7 | 3 | EFO_0004343 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MKMEGSRGRLRGGLG | 161 | Q9Y6K1 | |
| QSGAKMRMGPGRKRD | 26 | Q9Y570 | |
| KMMRGSRRGCVRLRG | 41 | Q96SU4 | |
| MKGGIRKDRRGGRML | 251 | P03372 | |
| FRGRGNHPKMGMLKR | 361 | P11387 | |
| KGLSGKKRRRERGMM | 1176 | Q8NDV7 | |
| GVTDLRGMLKRLKGM | 341 | Q14896 |